MediciNova, Inc.

NASDAQ:MNOV

Biotechnology

Healthcare
$1.33 -1.32%

-$0.02 today

Market cap
$68.14M
Beta
0.62
P/E (TTM)
-5.6
EPS (TTM)
-$0.24
52W Low $1.17High $1.96

Volume 0.12M

Average 0.04M

MNOV Other Current Liabilities

Short-term obligations not reported separately, such as accrued expenses.

MediciNova, Inc.NASDAQ: MNOV

Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Other current liabilities turns negative

Q1 FY2026 other current liabilities was -$165.2M, compared with $0 a year earlier. Over 3 fiscal years it compounded at +74.1% a year.

Context

  • Other current liabilities amounted to 386.8% of total assets at the end of Q1 FY2026, up 386.8 pp from a year earlier.
  • Other current liabilities increased in 2 of the last 3 fiscal years.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$165.2M-6434.2% QoQ
Last fiscal yearDec 2025
$971.07K+6.4% YoY
Year agoMar 2025
$0— since
Other Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+6.4%——
3-year CAGR+74.1%——
5-year CAGR——
10-year CAGR——

Other Current Liabilities history

USD · from the balance sheet

Latest · FY2025
971.07K USD
Year-over-year change
+6.4%
4-year CAGR
+15.4%

Other Current Liabilities vs competitors

How MNOV compares with its peers on the latest reported figures

  • MNOV's Mar 2026 other current liabilities of -$165.2M is the lowest of the 11 companies compared; the peer median is $2.29M.
  • Other current liabilities amounts to 386.8% of total assets for MNOV, versus a peer median of 1.3%.
MNOV Competitors Peer median
Other Current Liabilities for MNOV and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
IMUXImmunic, Inc.Mar 2026$5.53M +323.0%+39.7%2.9%
VXRTVaxart, Inc.Mar 2026$4.12M -31.7%+41.2%2.3%
TCRXTScan Therapeutics, Inc.Mar 2026$3.84M +72.7%+20.5%1.9%
FBIOFortress Biotech, Inc.Mar 2026$2.78M -44.5%-63.3%0.8%
PMVPPMV Pharmaceuticals, Inc.Mar 2026$2.42M -13.0%+16.1%2.5%
ACRVAcrivon Therapeutics, Inc. Common StockMar 2026$2.17M +1.9%+27.8%2.0%
CBUSCibus, Inc.Mar 2026$2.12M -31.3%+132.8%0.7%
RLMDRelmada Therapeutics, Inc.Mar 2026$1.11M +9.0%-19.4%0.5%
BMEABiomea Fusion, Inc.Mar 2026$159K -39.1%-35.7%0.3%
XBITXBiotech Inc.Mar 2026$0 —+64.3%0.0%
MNOVMediciNova, Inc.Mar 2026-$165.2M —+74.1%386.8%
Peer median (excluding MNOV) $2.29M-13.0%+24.2%1.3%

Competitors are the stored peer set for MNOV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents71.43M18.51M51M40.36M30.81M
Short-term Investments039.98M000
Net Receivables00000
Inventory00000
Other Current Assets00174.94K714.54K184.83K
Total Current Assets72.01M58.99M51.17M41.07M30.99M
Property, Plant & Equipment (Net)881.78K674.76K621.21K382.41K192.57K
Goodwill9.6M9.6M9.6M9.6M9.6M
Intangible Assets4.8M4.8M4.8M4.8M4.8M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets115.49K92.79K74.15K19K19K
Total Non-current Assets15.4M15.17M15.1M14.8M14.61M
Total Assets87.41M74.15M66.27M55.88M45.6M
Account Payables402.74K424.65K1M1.1M625K
Short-term Debt00000
Tax Payables00000
Deferred Revenue0000370.16K
Other Current Liabilities547.27K184.1K988.77K912.78K971.07K
Total Current Liabilities2.83M3.19M3.28M2.96M3.8M
Long-term Debt00000
Deferred Tax Liabilities00201.79K201.79K201.79K
Deferred Revenue (Non-current)00000
Other Non-current Liabilities201.79K201.79K410.66K211.46K17.13K
Total Non-current Liabilities896.47K725.41K612.45K413.25K218.92K
Total Liabilities3.73M3.91M3.89M3.37M4.02M
Common Stock49.04K49.05K49.05K49.05K49.22K
Retained Earnings(393.06M)(407.13M)(415.7M)(426.75M)(438.75M)
Accumulated OCI(98.88K)(115.28K)(118.09K)(135.15K)(127.18K)
Other Stockholders Equity(0)(1)000
Minority Interest00000
Total Equity83.68M70.24M62.38M52.5M41.59M
Total Debt826.64K681.12K215.93K193.77K194.33K
Net Debt(70.6M)(17.82M)(50.78M)(40.17M)(30.61M)

MediciNova, Inc.

NASDAQ:MNOV

Intrinsic Alpha fair value

Locked

Current Price

$1.33

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.